Adenosine receptor selective modulators

US7825255B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Ulrich Rosentreter · Binnen, DE
• Thomas Kramer · Wuppertal, DE
• Andrea Vaupel · Riehen, CH
• Walter Hubsch · Wuppertal, DE
• Nicole Diedrichs · Wuppertal, DE
• Thomas Krahn · Hagen, DE
• Klaus Dembowsky · Boston, US
• Johannes-Peter Stasch · Wuppertal, DE

Key dates

• Filing date: Feb 28, 2002
• Grant date: Nov 2, 2010
• Expiry date: Jul 26, 2027

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D405/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the compounds of formula (I), to a method for producing the same and to the use thereof as medicaments.